Accessibility Menu
Aurora Cannabis logo

Aurora Cannabis(TSX) ACB

Market CapCA$340.52MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2015)-90%
5 Year-94%
1 Year-20%
1 Month+39%
CA$5.25
-2.24%
-0.12Today
Aurora Cannabis last closing stock price
MetricPriceDate
Last closeCAD 5.252026-08-20
Aurora Cannabis stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.38%CAD 5.272026-08-13
1 month+38.89%CAD 3.782026-07-21
3 month+9.6%CAD 4.792026-05-22
Year to date-9.01%CAD 5.772025-12-31
1 year-20.21%CAD 6.582025-08-20
3 year-21.64%CAD 6.702023-08-21
5 year-93.87%CAD 85.702021-08-20
Since inception-89.68%CAD 52.032015-10-23

Aurora Cannabis Financials at a Glance

Market Cap

CA$340.52MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$287.96M

Net Income (TTM)

-CA$27.44M

EPS (TTM)

-CA$1.94

P/E Ratio

-2.71

Dividend

CA$0.00

Beta (Volatility)

1.92 (High)

Price

CA$5.25

Volume

399,574

Open

CA$5.35

Previous Close

CA$5.25

Daily Range

CA$5.17 - CA$5.38

52-Week Range

CA$3.59 - CA$9.33

Estimated Earnings Date

Nov 4, 2026

ACB News

Dices

Better Buy: Aurora Cannabis vs. Canopy Growth

Sushree MohantyFeb 16, 2022
GettyImages-1075376246

2 Ways Aurora Cannabis Could Pay the Price for Its Aggressive Growth Strategy

Prosper Junior BakinyOct 8, 2019
Time to sell

Aurora Cannabis and Cronos Group: Time to Take Profits?

George Budwell, PhDFeb 6, 2019
Marijuana leaf

Why Aurora Cannabis and Canopy Growth Caught Fire Today

George Budwell, PhDJan 10, 2019
indoor grow

Better Buy: Aurora Cannabis vs. Tilray

George Budwell, PhDJan 3, 2019
bud

Better Buy: OrganiGram Holdings Inc. vs. Aurora Cannabis

George Budwell, PhDOct 29, 2018
Marijuana with cash Getty Images-marijuana-leaf-on-top-of-stack-of-100-bills

What Marijuana Investors Must Learn From Aurora Cannabis' U.S. Debut

Dan CaplingerOct 24, 2018
ACB cannabis facility

4 Things Aurora Cannabis Did Right Before Its NYSE Debut

Dan CaplingerOct 22, 2018
Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Aurora Cannabis

Aurora Cannabis Inc. is a Canada-based firm specializing in the cultivation, processing, and global distribution of cannabis and its various derivative products. The company operates across a broad spectrum of the cannabis industry, from facility engineering and design to genetic research, production, and product development.

Products and Services
  • Diverse strains of dried cannabis, oils, capsules, and topical kits
  • Accessories including vaporizers, grinders, and lockable containers
  • Patient counseling and analytical product testing services
Growth Outlook
  • Expanding product lines in oral, topical, edible, and inhalable categories
  • Strong market presence with a diverse brand family including Aurora and MedReleaf
  • Commitment to advancing medical cannabis through ongoing research and development
Financial Highlights
  • Recent quarterly revenue of CAD 38 million, showing potential for recovery
  • Trailing twelve months (TTM) revenue of CAD 94 million, indicating growth
  • Current ratio of 5.94, reflecting strong liquidity position
Aurora Cannabis Inc. is positioned as a significant player in the cannabis industry, with a comprehensive approach that includes cultivation, processing, and distribution. The company offers a wide range of products catering to both medical and recreational users, supported by a robust network of retail and wholesale operations. The growth outlook appears promising, with ongoing product development and a commitment to expanding into new markets. Recent financial performance shows a quarterly revenue of CAD 38 million, which suggests a potential recovery trajectory. The trailing twelve months revenue of CAD 94 million further underscores the company's ability to generate income, despite challenges faced in the past. With a current ratio of 5.94, Aurora Cannabis demonstrates a strong liquidity position, which may provide a buffer against market fluctuations. The company's diverse brand portfolio and focus on research and development position it well for future growth in the evolving cannabis landscape.
AI Generated • Jul 23, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

1,028

CEO

Miguel Martin

Website

www.auroramj.com

Headquarters

Edmonton, AB T6X 1V8, CA

ACB Financials

Key Financial Metrics (TTM)

Gross Margin

32.08%

Operating Margin

-29.66%

Net Income Margin

-38.15%

Return on Equity

-21.00%

Return on Capital

-30.39%

Return on Assets

-17.83%

Earnings Yield

-36.90%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$340.52MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

64.86M

Volume

399.57K

Avg. Volume

458.46K

Financials (TTM)

Gross Profit

CA$98.69M

Operating Income

-CA$71.92M

EBITDA

-CA$180.64M

Operating Cash Flow

-CA$28.08M

Capital Expenditure

-CA$22.91M

Free Cash Flow

-CA$50.99M

Cash & ST Invst.

CA$149.12M

Total Debt

CA$22.68M

Aurora Cannabis Performance Analysis

Aurora Cannabis annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31CAD 231,583,4214.6%
20242024-03-31CAD 269,637,00016.4%
20252025-03-31CAD 288,911,0007.1%
20262026-03-31CAD 320,593,00011.0%
Aurora Cannabis sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-30-10.0%
Q32025-12-316.8%
Q42026-03-31-59.6%
Q12026-06-3077.7%
Aurora Cannabis annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31CAD -8.172.3%
20242024-03-31CAD -1.57-80.8%
20252025-03-31CAD 0.04N/A
20262026-03-31CAD -2.15N/A
Aurora Cannabis sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-30-237.0%
Q32025-12-31103.5%
Q42026-03-31-3213.2%
Q12026-06-3093.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2027YOY CHG

Revenue

CA$67.55M

-31.1%

Gross Profit

-CA$4.02M

-65.9%

Gross Margin

-5.95%

N/A

Market Cap

CA$340.52MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

CA$331.25K

N/A

Employees

1,028

N/A

Net Income

-CA$4.03M

+73.5%

EBITDA

-CA$43.47M

-280.4%

Quarterly Fundamentals

Name
Q1 2027YOY CHG

Total Cash

CA$149.12M

-19.8%

Total Debt

CA$22.68M

-77.7%

Accounts Receivable

CA$41.09M

+5.0%

Inventory

CA$187.54M

-17.8%

Long Term Debt

CA$16.81M

-53.7%

Short Term Debt

CA$5.88M

-91.0%

Return on Assets

-17.83%

N/A

Return on Invested Capital

-15.72%

N/A

Free Cash Flow

-CA$9.86M

-294.1%

Operating Cash Flow

-CA$4.45M

-143.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
XLY.TOAuxly Cannabis Group Inc.
CA$3.14-2.79%
CPH.TOCipher Pharmaceuticals Inc.
CA$14.32-0.28%
HITI.VHigh Tide Inc.
CA$3.39-0.00%
WEED.TOCanopy Growth Corporation
CA$1.45+1.40%

Trending Stocks

Symbol / CompanyPricePrice Chg
BITOProShares Trust - ProShares Bitcoin ETF
$9.81+0.06%
SPCXSpace Exploration Technologies
$134.00-0.04%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.88-0.03%
IBITiShares Bitcoin Trust
$41.20+0.06%

Questions About ACB

What is the current price of Aurora Cannabis?

Aurora Cannabis is trading at CA$5.25 per share.

What is the 52-week range for Aurora Cannabis?

Over the past 52 weeks, Aurora Cannabis has traded between CA$3.59 and CA$9.33.

How much debt does Aurora Cannabis have?

As of the most recent reporting period, Aurora Cannabis reported total debt of CA$22.68M.

How much cash does Aurora Cannabis have on hand?

Aurora Cannabis reported CA$118.39M in cash and cash equivalents in its most recent financial results.

What is Aurora Cannabis’s dividend yield?

Aurora Cannabis does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services